# FONDAPARINUX SODIUM

NDC: 55150-233
Generic name: FONDAPARINUX SODIUM
Labeler / Manufacturer: Eugia US LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20171226

FDA application: ANDA206918

## Active ingredients

- FONDAPARINUX SODIUM: 10 mg/.8mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55150-233"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55150-233
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8ea61d0d-4403-4d9f-a946-85a459cc0aa0